Galectin-3, A Novel Endogenous Trem2 Ligand, Regulates Inflammatory Response and Aβ Fibrilation in Alzheimer’s Disease
Antonio Boza‐Serrano, Rocío Ruiz, Raquel Maria Sanchez-Varo, Yiyi Yang, Juan García‐Revilla, Itzia Jiménez-Ferrer, Agnes Paulus, Malin Wennström, Anna Vilalta, David H. Allendorf, José Carlos Dávila, Christopher J.R. Dunning, John Stegmayr, Sebastián Jiménez, The Netherland Brain, , Tomas Deierborg
This study identifies galectin-3 as a novel endogenous TREM2 ligand that regulates microglial activation and Aβ fibrillation in Alzheimer’s disease.
bioRxiv · Dec 4, 2018 · PreprintNeuroscience